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Abstract
Objective: To assess the inﬂuence of changes in cardiorespiratory ﬁtness (CRF) after exercise training
on mortality risk in a cohort of self-referred, apparently healthy adults.
Patients and Methods: A total of 683 participants (404 men, 279 women; mean age: 42.711.0 y)
underwent two maximal cardiopulmonary exercise tests (CPX) between March 20, 1970, and
December 11, 2012, to assess CRF at baseline (CPX1) and post-exercise training (CPX2). Participants
were followed for an average of 29.810.7 years after their CPX2. Cox proportional hazards models
were performed to determine the relationship of CRF change with mortality, with change in CRF as a
continuous variable, as well as a categorical variable. A Wald chi-square test was used to compare the
coefﬁcients estimating the relationship of peak oxygen consumption (VO2peak) at CPX1 with VO2peak
measured at CPX2 with time until death for all-cause mortality.
Results: During the follow-up period there were 180 deaths. When assessed independently, there were
20% (95% CI, 10e49%) and 38% (95% CI, 7e66%) lower mortality risks per 1 metabolic equivalent
improvement in CRF (P<.01) in men and women, respectively, after multivariable adjustment. Those
that remained unﬁt had w2-fold higher risk for all-cause mortality compared with those that remained ﬁt
and CRF at CPX2 was a stronger predictor of all-cause mortality than at CPX1 (P¼.02).
Conclusion: Improving CRF through exercise training lowers mortality risk. Clinicians should
encourage individuals to participate in exercise training to improve CRF to lower risk of mortality.

ow cardiorespiratory ﬁtness (CRF) has
been established as an important predictor of cardiovascular disease
(CVD), cancer, and all-cause mortality since
the late 1980s.1-6 This has been studied in
various populations using a variety of
methods to assess CRF,3 more recently
including cardiopulmonary exercise testing
(CPX), which is widely considered to be the
gold standard method for measuring CRF.7,8
Aerobic exercise training is widely recommended, particularly in those with low CRF,
to improve CRF. Exercise training programs
typically result in improvements in CRF of 1
to 2 metabolic equivalents (METs) following

L

3 to 6 mo of moderate to vigorous exercise,
which may inﬂuence mortality risk.9,10 Most
investigations of the relationship between
CRF and mortality have only observed the
relationship from a baseline measure of
CRF.6,11-18 It is presently unknown if assessing CRF after a short-term exercise training
program would be more effective in determining a patient’s risk, as is commonly done
with other risk factors following prescribed
therapies to determine effectiveness in
improving patient health and reducing risk
for adverse health outcomes.
The association between short-term (<1
year) changes in CRF post-exercise training

and mortality risk has only been studied in patients with established CVD attending cardiac
rehabilitation. Martin et al19 showed that
participation in a 12-week cardiac rehabilitation program resulted in a 13% reduction in
mortality with each MET increase in CRF estimated from an exercise test (CRFe) in the overall sample, and a 30% reduction in those CVD
patients categorized as low ﬁt at baseline. However, there have been no studies that have
assessed the association between change in
directly measured CRF, obtained from CPX
with short-term exercise training and allcause mortality in apparently healthy men
and women.
Therefore, the primary aim of this study
was to assess the association between changes
in CPXederived CRF following a short-term
aerobic exercise training program and the risk
for all-cause mortality in apparently healthy
men and women. Secondly, this study aimed
to compare CPXederived CRF measured at
baseline (CPX1) to that measured after shortterm exercise training (CPX2) in predicting
mortality risk.
METHODS
A sample of 683 apparently healthy participants (404 men, 279 women), ranging from
20 to 77 years of age (mean age at CPX1 for total sample, 42.711.0 y; mean age for men,
42.210.6 y, mean age for women,
43.511.5 y) was obtained from the Ball State
Adult Fitness Longitudinal Lifestyle Study
(BALL ST) cohort between March 20, 1970,
and December 11, 2012. Participants were
residents of east-central Indiana who were
self-referred to this university-based exercise
program and were considered apparently
healthy, deﬁned as free from known CVD
(history of cardiac arrest, coronary artery disease, heart failure, myocardial infarction,
symptomatic valvular heart disease, peripheral artery disease, and stroke) and cancer at
baseline (n¼17). CVD diagnosis was selfreported and veriﬁed by written physician
conﬁrmation in 24 participants; therefore,
these individuals were excluded from all analyses. Participants were included if they were
18 years of age or older when they joined the
program and performed two CPXs using the

same mode of exercise, with CPX2 occurring
after 3 to 8 months of exercise training. Participants were excluded if they did not meet the
deﬁned maximal effort criteria of a respiratory
exchange ratio of 1.0 during both exercise
tests (n¼44), or had <5.0 years of mortality
follow-up from the second test (n¼16) in an
attempt to control for unknown underlying
disease. This study was reviewed by the Ball
State University Institutional Review Board
and determined exempt as only de-identiﬁed
data were used.
Clinical Measurements
A full description of the procedures involved
in the resting clinical measurements performed before both CPXs has been provided
previously.20,21 In summary, participants
completed a health history questionnaire,
providing demographic information, personal and family medical history, medication
usage, and lifestyle behaviors. Information
gained from the questionnaire was used to
screen for medical contraindications and/or
physical limitations to CPX.
Lifestyle behaviors of physical activity
(PA) and smoking were self-reported. PA status was classiﬁed as inactive or active, with
active being designated if participants reported
engagement in regular PA, meeting the 2008
US PA recommendations for aerobic activity
for adults.22 Smoking status was categorized
as current smoker, including those who used
cigarettes or quit within the past year, or
nonsmoker at baseline.
Clinical measurements including resting
heart rate, blood pressure, anthropometrics
(height, weight, and waist circumference),
12-lead electrocardiogram, and blood chemistry (8 h post-prandial), were performed by
trained technicians using standardized laboratory procedures.20,21 These measurements
were used to determine the presence of risk
factors, including obesity, hypertension, dyslipidemia, and impaired fasting glucose,
deﬁned according to current accepted atherosclerotic CVD risk factor criteria.23
Assessment of CRF
CPXs were performed using a treadmill or cycle, to determine peak oxygen consumption

(VO2peak). The mode of exercise was chosen
based on participant preference, comfort, and
the presence of functional limitations as determined through health history questionnaire.
The protocol was chosen to target achieving
peak effort within 8 to 12 minutes based on
the participant’s self-reported PA level or
CRFe obtained using a validated non-exercise
prediction equation.21 Throughout the CPX,
gas exchange measurements were collected using an open-circuit spirometry metabolic
testing system. Standardized procedures were
followed for metabolic cart calibration and all
tests were supervised by trained clinical exercise physiologists, with additional medical supervision when appropriate. Participants were
encouraged to exercise to volitional fatigue
and a respiratory exchange ratio 1.0 was
used as an objective indicator of peak effort.
CRF was expressed as VO2peak in units of
mL$kg-1$min-1. VO2peak was determined by
averaging the highest two to three consecutive
measured VO2 values within 2 mL$kg-1$min-1,
occurring in the last 2 minutes of the CPX.
Exercise Training
Following CPX1, participants were provided
an individualized exercise prescription developed by clinical exercise physiologists based
on their CPX results. The program consistently followed the at-the-time current recommendations ﬁrst established by the American
Heart Association24 and later by the American
College of Sports Medicine which are updated
approximately every 5 years.23,25 The exercise
prescription was created with the goal of
improving CRF by progressively increasing
PA volume (intensity, duration, and frequency), which has previously been shown
in this cohort.26 All participants who attended
the program regularly, operationally deﬁned as
approximately >75% of the sessions, were
reassessed after 3 to 8 months of exercise
training. CPX2 was performed using the
same mode of exercise and following the
same protocol as performed with CPX1.
Outcomes and Follow-up
All participants were followed from the date
of CPX2 through November 2017 or until
their date of death. The National Death

Index was the primary data source for
obtaining vital status between 1979 and
2016. Those identiﬁed by the National Death
Index as deceased due to accidental causes
(n¼6) were excluded from analyses.
Statistical Analysis
SPSS V. 24 (SPSS, Inc., Chicago, IL), was
used for all statistical analyses. Descriptive
statistics were performed to summarize baseline characteristics of the participants and a
univariate analysis of variance and chisquare goodness of ﬁt test were used when
appropriate to test for signiﬁcant differences
between sexes, CRF level (low ﬁt [quartile I]
vs ﬁt [quartiles II, III, IV]), and vital status.
A paired t test was used to assess the differences between baseline CRF and CRF after
exercise training, both expressed as a continuous variable (mL$kg-1$min-1). Cox proportional hazards models were used to
determine hazard ratios and 95% CIs associated with the change in CRF as related to allcause mortality for both sexes. The change
in CRF was computed as the difference between baseline and post-training VO2peak,
and was used as a continuous variable in analyses. Additional models were performed
with change in CRF level, as a categorical
variable, as the covariate. CRF levels were
initially grouped into quartiles based on the
Fitness Registry and the Importance of Exercise National Database (FRIEND),27,28
which provides age- and sex-speciﬁc reference values for CPXederived CRF for adults
in the United States. Analyses were performed to determine if there were signiﬁcant
differences between ﬁtness quartiles in mortality risk at baseline and post-training test.
As there were no signiﬁcant differences in
risk between quartiles II-IV, these were
grouped together and categorized as the ﬁt
group (26th percentile). Quartile I was
classiﬁed as the low-ﬁt group (25th percentile). The change in CRF level was then categorized into three groups, those that
remained low-ﬁt, those that remained ﬁt,
and those that improved their CRF level
moving from the low-ﬁt to ﬁt group. The
Cox proportional hazards models were ﬁt
to the data and the continuous models

TABLE 1. Descriptive Characteristics of BALL ST Cohort at CPX1 and After CPX2a
All (N¼683)

Women (n¼279)

Men (n¼404)

CPX 1

CPX 2

CPX 1

CPX 2

CPX 1

CPX 2

Characteristics
VO2peak (mL$kg-1$min-1)b
VO2peak (L$min-1)b
METs*
FRIEND (percentile)
Weight (kg)
BMI (kg$m-2)b
WC (cm)b
SBP/DBP (mm Hg)b
RHR (bpm)b
Total cholesterol (mg$dL-1)b
Blood glucose (mg$dL-1)

32.38.6
2.550.8
9.22.5
54
79.217.0
26.04.7
88.914.2
120/7713/10
6823
211.245.5
93.919.2

37.29.2
2.860.9
10.62.6
64
76.716.3
25.54.8
85.513.0
117/7613/10
6410
206.342.3
94.218.6

27.57.0
1.880.4
7.92.0
50
69.615.8
25.75.8
80.613.7
118/7614/10
709
205.342.7
91.820.0

31.67.5
2.110.5
9.02.1
68
68.314.4
25.15.2
78.912.4
115/7213/12
679
200.137.9
92.220.9

37.29.2
2.860.9
10.62.6
59
82.715.0
26.14.0
92.110.3
121/7712/12
6410
212.045.6
96.116.6

41.18.2
3.380.7
11.72.3
63
77.216.4
25.74.8
86.513.0
117/7613/10
619
207.143.3
94.318.7

Risk factors
Obesity (%)b
Hypertension (%)*
Dyslipidemia (%)b
Pre-diabetes /diabetes (%)b
Physical inactivity (%)
Smoking (%)

24
20
55
30
78
11

18
17
50
29
d
10

26
18
41
21
79
7

20
14
37
19
d
6

17
20
62
41
78
13

18
18
52
31
d
11

BALL ST ¼ Ball State Adult Fitness Longitudinal Lifestyle Study; CPX1/2 ¼ cardiopulmonary exercise testing before/after; BMI ¼ body mass index, bpm ¼ beats per minute,
DBP ¼ diastolic blood pressure, FRIEND ¼ Fitness Registry and the Importance of Exercise National Database, METs ¼metabolic equivalents, RHR ¼ resting heart rate;
SBP ¼ systolic blood pressure, VO2peak ¼ peak oxygen consumption, WC ¼ waist circumference.
b
Signiﬁcantly different results between CPX1 and CPX2 within sexes; P.05.
a

were analyzed unadjusted (model 1),
adjusted for VO2peak at baseline (model 2),
and then with further adjustment for baseline age, examination year, and the change
in confounding CVD risk factors (model 3;
body mass index, systolic blood pressure,
fasting blood glucose, total cholesterol,
expressed continuously, and smoking status), which were computed as the change
in each variable between CPX1 and CPX2.
The categorical models were analyzed unadjusted (model 1), adjusted for change in
VO2peak (model 2), and then with further
adjustment for all variables listed in the
multivariable model above (model 3). A
Wald chi-square test was used to compare
the coefﬁcients estimating the relationship
of VO2peak at CPX1 to VO2peak measured at
CPX2 with time until death for all-cause
mortality. These models were analyzed
with VO2peak at both tests as covariates
only and then further adjusted for age and
sex. To assess the assumption of

proportional hazards, which underlies the
Cox model, Schoenfeld residuals were examined.29 The relationships between these residuals and the model covariates were not
statistically signiﬁcant (P>.05), indicating
that the proportional hazards assumption
was met.

RESULTS
VO2peak was 4.9 mL$kg-1$min-1 (w15%)
higher (P¼.04) after short-term training
compared with baseline for the overall sample. Further, the overall risk factor proﬁle
of subjects was improved following participation in the exercise training program
(Table 1). In addition to becoming physically active, the prevalence of obesity, hypertension, and dyslipidemia were reduced
(P¼.01).
Participants were followed for an average
of 29.8  10.7 y. During this period 180 subjects died (129 men, 51 women).

The Cox proportional hazards models
showed an inverse relationship between per
unit increase in VO2peak (mL$kg-1$min-1)
and risk for all-cause mortality (P<.05)
(Table 2). The relationship remained signiﬁcant after adjustment for baseline VO2peak
and in the multivariable adjusted model. Speciﬁcally, a 1 mL$kg-1$min-1improvement was
found to be associated with a 7% (95% CI,
2e11%) lower risk for all-cause mortality
(P¼.02) after multivariable adjustment. This
corresponded to a 25% lower risk per 1
MET improvement. The relationship between
change in VO2peak and all-cause mortality
remained signiﬁcant when men and women
were assessed independently (Table 2). In
men, there was a 6% (95% CI, 3e14%) lower
risk for all-cause mortality per 1 mL$kg1$
min-1 VO2peak (P¼.01), after multivariable
adjustment. However, the risk reduction increase was found to be greater in women,
with an 11% (95% CI, 2e19%) lower risk
per each 1 mL$kg-1$min-1 increase in VO2peak

TABLE 2. Hazard Ratios for All-Cause Mortality
According to per 1 mL$kg-1$min-1 change in
VO2peaka
All

HR (95% CI)

Model 1b

0.955 (0.92e0.99)

Model 2c

0.935 (0.90e0.97)

Model 3d

0.929 (0.89e0.98)

Men
Model 1
Model 2
Model 3

0.968 (0.93e1.01)
0.937 (0.90e0.98)
0.944 (0.86e0.97)

Women
Model 1
Model 2
Model 3e

0.904 (0.84e0.98)
0.840 (0.77e0.92)
0.890 (0.81e0.98)

CRF ¼ cardiorespiratory ﬁtness, HR ¼ hazard ratio;
VO2peak ¼ peak oxygen consumption.
b
Model 1 unadjusted.
c
Model 2 adjusted for baseline VO2peak.
d
Model 3 adjusted for age, sex, examination year, baseline
VO2peak, and change in risk factors (continuous variables
include body mass index, systolic blood pressure, fasting
blood glucose, and total cholesterol, as well as the categorical
variable smoking status).
e
As there were fewer deaths in women, the analysis was
adjusted for age, gender, examination year, baseline VO2peak,
and change in risk factors (continuous variables include body
mass index, fasting blood glucose, and total cholesterol).

(hazard ratio per mL$kg-1$min-1 improvement, 0.89; 95% CI, 0.81e0.98); P¼.04).
The inverse relationship between per unit increase in CRF and risk for all-cause mortality
was also signiﬁcant with absolute VO2peak
(L$min-1) (P<.05).
At baseline, 181 subjects (130 men, 51
women) were characterized as low-ﬁt
(25th percentile). After 4.2  1.5 months
of participation in an exercise training program, 132 of these subjects (93 men, 39
women) improved their CRF to the ﬁt category. The cumulative hazard over the
follow-up period of the three CRF categories
associated with the short-term training for
all-cause mortality is shown in the
Figure 1. Results from the Cox proportional
hazards models for all-cause mortality
showed those who did not improve their
CRF above the low-ﬁt threshold had an
approximately 2-fold higher risk of dying
from all causes compared with those who
were above the low-ﬁt threshold at both
CPX1 and CPX2 (P<.001). The strength of
the association with mortality remained signiﬁcant after further adjustment for change
in VO2peak, as well as in the multivariable
adjusted model. Those who improved their
CRF above the low-ﬁt threshold had no difference in mortality rates compared with
those who maintained their level in the ﬁt
classiﬁcation.
Results from the Wald chi-square test of
equality comparing CPX-derived CRF at baseline versus after short-term exercise training
showed the value measured at CPX2 was a
stronger predictor of all-cause mortality
than at CPX1 (P¼.02) (Table 3). This relationship remained signiﬁcant after further
adjustment for age and sex (P¼.05).

a

DISCUSSION
This study found a strong, inverse relationship between the change in CRF after shortterm exercise training and all-cause mortality
equating to a 25% (95% CI, 7e38%) lower
mortality risk per MET improvement. This
suggests greater improvement in CRF
following short-term exercise training results
in larger reductions in risk of all-cause mortality in apparently healthy adults. This

1.2
Change in fitness
Remained low fit
Low fit to fit
Remained fit

1.0
Cumulative hazard

association was independent of sex and baseline CRF and was observed over a long followup period of more than 28 years on average.
This relationship remained signiﬁcant when
adjusted for changes in other risk factors,
including body mass index, and when
VO2peak was expressed as L/min. The exercise
training resulted in a 15% increase in CRF in
our cohort, which is consistent with the expected improvement that is considered to be
5% to 30%.18 These ﬁndings further support
the importance of CRF and lifestyle modiﬁcations designed to improve CRF for long-term
health outcomes.
The ﬁndings from the current study also
showed that CRF after short-term exercise
training is a stronger predictor of mortality
than a single baseline measure of CRF.
This emphasizes the importance of screening
for low CRF as a risk factor and subsequently prescribing an exercise training program to improve CRF. This is similar to how
clinicians screen for and address other risk
factors, through an initial assessment, prescription of a therapy for the risk factor,
and subsequent follow-up to determine the
effectiveness of the prescription in
improving health outcomes.
The only other study to date that has
assessed the association of changes in CRF
analyzed the changes in CRFe following a
12-week exercise training program with
mortality risk was performed in cardiac patients (76% men; mean age, 6010 y).19
The patients’ improvement in CRFe was
(w14%) similar to what we observed in
the BALL ST cohort. They also found an inverse relationship between CRFe change and
mortality risk; however, their observed
reduction in mortality risk of 13% per MET
increase was notably lower than the 25%
per MET value observed in the current
study. One explanation for the greater reduction in risk observed in the current study
may be due to the differences in the characteristics of the cohorts (apparently healthy vs
cardiac disease). However, the differences
may also be due to the use of CPX to directly
measure CRF in the current study versus the
estimation method used in the previous
study. The increased accuracy of CPX allows
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FIGURE 1. Cumulative hazard of change in cardiorespiratory ﬁtness group
with mortality during follow-up period.

for a more precise determination of the
change in CRF in response to exercise
training, which may provide a more sensitive
risk stratiﬁcation.30,31
The current cohort was also categorized
into ﬁtness groups based on age- and sexspeciﬁc normative data from the FRIEND
registry.27,28 Those who did not improve
their ﬁtness level above the 25th percentile
had an approximately 2-fold greater risk,

TABLE 3. Comparison the Relationship Between
VO2peak Measured at Baseline (CPX1) and After
Short-Term Training (CPX2) With Mortality
Outcomesa
Wald chi-square
test of equality

Absolute
parameter estimate

Model 1b
CPX2 VO2peak
CPX1 VO2peak

0.047c
0.013

Model 2d
CPX2 VO2peak
CPX1 VO2peak

0.035c
0.007

CPX1/2 ¼ cardiopulmonary exercise at baseline/after;
Vo2peak ¼ peak oxygen uptake.
b
Model 1 unadjusted.
c
P.05.
d
Model 2 adjusted for age and sex.
a

compared with those who were above the
25th percentile at both CPX1 and CPX2.
The mortality risk of those who improved
their ﬁtness at CPX2 above the 25th percentile was no different than the group who
were above the 25th percentile on both
CPX. It is known that the training effect is
variable for different individuals,32 and it is
also understood that the rate of improvement is not uniform.10 A strength of this
cohort is the wide range of demographic
characteristics which likely contributed to
this variation in CRF response to shortterm exercise training. These ﬁndings suggest that improvement of CRF, at least above
the 25th percentile, is important to achieve
reduction in mortality risk. This shows the
importance of performing periodic CRF assessments, in this case to evaluate response
to short-term exercise training. Those who
have not responded adequately would
require modiﬁcations to their exercise prescription, as increasing exercise volume
and intensity have been shown to improve
CRF in individuals with a below-normal
initial response.32
Several cohorts have also assessed the association between long-term changes in CRF
and mortality (>4 years between assessments).33-38 All of these studies reported
that maintaining or improving CRF or
CRFe resulted in lower risk of mortality.
However, these previous longitudinal studies
did not directly assess the inﬂuence of exercise trainingeinduced improvements in CRF
on mortality risk. The current study assessed
this relationship after a short-term exercise
training program in apparently healthy
adults and our ﬁndings support that
exercise-related increase in CRF decreases
mortality risk.
Strengths and Limitations
The primary strengths of this study include
assessing CRF after a short-term exercise
training program, examining a population of
apparently healthy men and women, and
directly measuring CRF with CPX. Presently
there is only one other report of the CRFmortality relationship after short-term exercise training, and that was performed with

cardiac patients and assessment of CRFe.
The BALL ST cohort also consists of men
and women across a wide distribution of
ages and number of risk factors and therefore
may be representative of the population that
many clinicians see on a regular basis. The
long follow-up period is another notable
strength, as it permits the understanding of
how post-training improvements in CRF
may alter mortality risk over time, as this
study had a mean follow-up of approximately
30 years with a range of 5 to 46 years. Additionally, the use of population-speciﬁc CRF
groups based on the FRIEND registry, which
standardizes CRF across age- and sex-speciﬁc
percentiles,27,28 increases the generalizability
of our results to the US adult population, and
provides clinicians with a tool to more easily
interpret mortality by age and sex.
The limitations of the present study
include a convenience sample of a selfreferred cohort comprised of more than 90%
non-Hispanic white persons, all of whom
could achieve maximal effort on an exercise
test. As such, caution should be used when
generalizing these results. Additionally, the
low number of deaths in each CRF group,
when further divided by sex, decreased statistical power for the sex-speciﬁc analyses and
therefore were not performed for the categorical models. Future studies should assess the
relationship between the change in directly
measured CRF after short-term exercise
training and all-cause mortality in men and
women with a greater number of mortality
outcomes, as well as in a greater distribution
of racial and ethnic backgrounds. Another
limitation was that lifestyle behaviors used
in analyses including smoking and physical
activity were self-reported. Finally, information on exercise habits and further changes
in CRF following CPX2 were not available.
Therefore, future studies should assess the association between changes in CRF and mortality in a large diverse cohort that has longterm exercise training adherence.
CONCLUSION
This is the ﬁrst study to quantify the inﬂuence
of short-term exercise trainingeinduced
changes in CRF on mortality risk in

apparently healthy men and women. These
ﬁndings show the importance of adopting exercise training as an effective method to
improve CRF and decrease mortality risk. Clinicians should screen patients for low CRF,
similar to their screening of other CVD risk
factors and prescribe exercise training for
those with low CRF and to all as a healthy lifestyle intervention. Reassessment of CRF after
exercise training is important to establish if
the response is adequate or if additional modiﬁcations are needed for the individual’s exercise prescription.
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